摘要:核医学在不明原因发热中应用的适宜使用标准
美国核医学与分子影像学会、美国感染病学会和美国核医学学院组成独立专家工作组,系统复习成人及儿童不明原因发热(FUO)核医学影像文献,依据2014年《保护医疗保险准入法》制定适宜使用标准(AUC)。工作组指出当前文献存在局限,需要设计良好的前瞻性多中心研究,并基于已发表数据共识和专家意见形成常见临床场景推荐;因FUO与不明原因炎症(IUO)标准相似(除发热>38.3°C外)且最常见病因相似,专家组认为FUO的核医学影像推荐也适用于IUO。
要点
- FUO诊断首选详细病史、体格检查、血常规、胸片、尿常规及培养、电解质、肝酶、血沉和C反应蛋白。
- 核医学检查(包括18F-FDG PET和PET/CT)通常作为二线检查,在诊断流程中作用日益重要。
- 专家组认为FUO的核医学影像推荐也适用于IUO,因两者标准相似(除发热>38.3°C外)且最常见病因相似。
核心结论
- 工作组基于已发表数据共识和专家意见,为成人和儿童FUO常见临床场景制定核医学影像适宜使用推荐。
- 专家组认为FUO的核医学影像推荐也适用于IUO,因两者标准相似(除发热>38.3°C外)且最常见病因相似。
研究设计与样本
- 美国核医学与分子影像学会、美国感染病学会和美国核医学学院组成独立专家工作组,系统复习成人及儿童FUO核医学影像文献并制定AUC。
- 该过程依据2014年《保护医疗保险准入法》进行,该法要求转诊医生在开具先进诊断影像服务前通过临床决策支持机制咨询AUC。
- 工作组完整发现与讨论于2023年1月8日发表。
主要发现
- FUO诊断流程始于详细病史和体格检查、全血细胞计数及分类、胸片、尿常规及培养、电解质组合、肝酶、血沉和C反应蛋白水平。
- 其他影像检查包括核医学检查通常作为二线检查,18F-FDG PET和PET/CT在诊断流程中作用日益重要。
- 工作组指出当前FUO核医学影像文献存在局限,需要设计良好的前瞻性多中心研究。
关键数值与推荐
- 完整AUC文件包含对不明原因炎症(IUO)的讨论,IUO为近期描述的疾病实体。
- FUO与IUO标准相似,仅发热阈值不同(FUO要求发热>38.3°C [100.9°F]),且两者最常见病因相似。
临床怎么用
- AUC最终文件旨在帮助转诊医疗提供者在FUO患者中适当地使用核医学影像检查。
- 本摘要回顾理由、方法和主要发现,并指引读者参阅完整AUC文件。
局限性
- 工作组指出当前FUO核医学影像文献存在局限,需要设计良好的前瞻性多中心研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The diagnostic work-up of patients with fever of unknown origin (FUO) begins with a thorough history and physical examination, complete blood count with differential, chest x-ray, urinalysis and culture, electrolyte panel, liver enzymes, erythrocyte sedimentation rate, and C-reactive protein level. Additional imaging procedures, including nuclear medicine tests, are generally used as second-line procedures, with 18F-FDG PET and PET/CT assuming increasingly important roles in the diagnostic work-up. The Society of Nuclear Medicine and Molecular Imaging, the Infectious Diseases Society of America, and the American College of Nuclear Medicine convened an autonomous expert work group to comprehensively review the published literature for nuclear imaging in adults and children with FUO and establish appropriate use criteria (AUC). This process was performed in accordance with the Protecting Access to Medicare Act of 2014, which requires that all referring physicians consult AUC by using a clinical decision support mechanism before ordering advanced diagnostic imaging services. The complete findings and discussions of the work group were published on January 8, 2023, and are available at https://www.snmmi.org/ClinicalPractice/content.aspx?ItemNumber=15666 The AUC in the final document are intended to assist referring health care providers in appropriate use of nuclear medicine imaging procedures in patients with FUO. The work group noted limitations in the current literature on nuclear medicine imaging for FUO, with the need for well-designed prospective multicenter investigations. Consensus findings from published data and expert opinions were used to create recommendations in common clinical scenarios for adults and children. Included in the complete document is a discussion of inflammation of unknown origin (IUO), a recently described entity. In view of the fact that the criteria for FUO and IUO are similar (except for fever > 38.3°C [100.9°F]) and that the most common etiologies of these 2 entities are similar, it is the expert opinion of the work group that the recommendations for nuclear medicine imaging of FUO are also applicable to IUO. These recommendations are included in the full guidance document. This summary reviews rationale, methodology, and main findings and refers the reader to the complete AUC document.
引用
- Palestro CJ, Abikhzer G, Bar-Sever Z, et al. Summary: Appropriate Use Criteria for the Use of Nuclear Medicine in Fever of Unknown Origin. J Nucl Med. 2024. PMID: 39327014. doi:10.2967/jnumed.124.268797
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。